Keller said he received more than a dozen cancer treatments during the course of his playing career before a doctor informed ...

Ahead of the readouts, BMS and J&J have started an educational push called “Change the Target. Change What’s Possible,” they announced Tuesday. The campaign is designed to inform clinicians who manage ...

After three years, the students will have an exit option with a UG degree, and if they pursue the fourth year, they will ...

More than 8 million people in the U.S. take blood thinners, also called anticoagulants. Many are prescribed the drugs after ...

ABP Course Guide: Choosing the right course after Class 12 is a crucial step for students interested in leadership, ...

Discover all of the undergraduate courses offered by CUET UG 2026, except BA and BSc. Learn about the BBA, B.Tech, B.Voc, Integrated Law, and Fine Arts programs offered by prestigious central and ...

President Donald Trump condemned but did not apologise for a video on his social media account depicting Democratic former ...

Insilico Medicine ("Insilico") (3696.HK), a clinical-stage biotechnology company powered by generative artificial intelligence (AI), today announced the appointment of Halle Zhang, PhD (Med), as Vice ...

Bristol Myers Squibb and Johnson & Johnson have said they will stop development of their oral Factor XIa inhibitor milvexian in acute coronary syndrome after a disappointing trial result. The decision ...

Bristol-Myers Squibb's flurry of dealmaking has continued with en expansion of its partnership with BridgeBio on drugs targeting SHP2, in the hope of combining them with its cancer immunotherapy ...

AGNC Investment (AGNC) delivered Q4 earnings on Monday that fell short of the consensus estimate, even as mortgage spreads to ...

Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) will be announcing earnings results this Thursday before the bell. Here’s what to expect.